Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![JohnZidar Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1115443829161713666.png) John Zidar [@JohnZidar](/creator/twitter/JohnZidar) on x 5913 followers
Created: 2025-07-23 01:01:07 UTC

After⏲Hours 4:01
$ABVX - Abivax 
🔹Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod
🔹Its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis

![](https://pbs.twimg.com/media/GwgP1XhXEAA-Bic.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947824261059776788/c:line.svg)

**Related Topics**
[$abvx](/topic/$abvx)

[Post Link](https://x.com/JohnZidar/status/1947824261059776788)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

JohnZidar Avatar John Zidar @JohnZidar on x 5913 followers Created: 2025-07-23 01:01:07 UTC

After⏲Hours 4:01 $ABVX - Abivax 🔹Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod 🔹Its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis

XXX engagements

Engagements Line Chart

Related Topics $abvx

Post Link

post/tweet::1947824261059776788
/post/tweet::1947824261059776788